HUTCHMED (China) (HMDCF) Change in Cash (2018 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly Change in Cash came in at $240.2 million in Q2 2021, up 392.01% year-over-year from $48.8 million in Q2 2020, and up 116.52% quarter-over-quarter from $110.9 million in Q1 2021.
Analysis
HUTCHMED (China) (HMDCF) Change in Cash (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Change in Cash for 4 consecutive years, with $240.2 million the latest figure, recorded in Q2 2021.
- On a quarterly basis, Change in Cash rose 392.01% year-over-year to $240.2 million in Q2 2021; TTM through Jun 2021 was $280.0 million, a 971.91% increase from a year earlier, with the FY2025 full-year figure at -$86.2 million, up 31.69% from the prior year.
- Change in Cash was $240.2 million for Q2 2021 at HUTCHMED (China), up from $110.9 million in the prior quarter.
- Over five years, Change in Cash peaked at $240.2 million in Q2 2021 and troughed at -$82.3 million in Q2 2020.
- A 4-year average of $26.6 million and a median of $7.6 million in 2019 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash sank 1159.26% in 2020 and jumped 899.31% in 2021, its largest moves.
- Over 4 years, Change in Cash stood at -$29.6 million in 2018, then jumped by 180.17% to $23.7 million in 2019, then plunged by 446.53% to -$82.3 million in 2020, then soared by 392.01% to $240.2 million in 2021.
- The last three Change in Cash figures came in at $240.2 million (Q2 2021), $110.9 million (Q1 2021), and -$82.3 million (Q2 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.49 Bn | 198.50 Bn | 7.24 Bn | 1.95 Bn |
| 2 | Gilead Sciences | 180.93 Bn | 177.75 Bn | 6.22 Bn | -4.45 Bn |
| 3 | Vertex Pharmaceuticals | 132.39 Bn | 124.53 Bn | 2.84 Bn | 649.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.17 Bn | 74.18 Bn | 3.93 Bn | -504.60 Mn |
| 5 | Argenx Se | 61.05 Bn | 55.87 Bn | 1.37 Bn | - |
| 6 | Moderna | 55.19 Bn | 50.05 Bn | 52.00 Mn | -185.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.99 Bn | 30.68 Bn | 992.69 Mn | -2.94 Mn |
| 8 | Biogen | 31.30 Bn | 30.01 Bn | 1.96 Bn | -2.09 Bn |
| 9 | Roivant Sciences | 29.91 Bn | 29.91 Bn | 1.16 Mn | -170.44 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 240.19 Mn |
| Mar 31, 2021 | 110.93 Mn |
| Jun 30, 2020 | -82.26 Mn |
| Mar 31, 2020 | 11.10 Mn |
| Dec 31, 2019 | 23.74 Mn |
| Sep 30, 2019 | 15.31 Mn |
| Jun 30, 2019 | -6.53 Mn |
| Mar 31, 2019 | 4.11 Mn |
| Dec 31, 2018 | -29.61 Mn |
| Sep 30, 2018 | 42.93 Mn |
| Jun 30, 2018 | -2.29 Mn |
| Mar 31, 2018 | -8.36 Mn |